Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.64 |
| ▸ | HTR2B | P41595 | 1/20 | 0.64 |
| ▸ | GRB2 | P62993 | 1/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 7/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.56 |
| ▸ | NOS3 | P29474 | 2/20 | 0.55 |
| ▸ | NOS1 | P29475 | 2/20 | 0.55 |
| ▸ | NOS2 | P35228 | 2/20 | 0.55 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | PPARA | Q07869 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.54 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.53 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.53 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29557134 | 1.00 | HTR2A (0.64) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| SCHEMBL503602 | 1.00 | HTR2A (0.64) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| SCHEMBL44155 | 1.00 | HTR2A (0.64) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| SCHEMBL29478401 | 1.00 | HTR2A (0.64) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| Hydrochloric Acid SCHEMBL10584250 | 0.98 | HTR2A (0.62) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| Hydrochloric Acid SCHEMBL6775624 | 0.98 | HTR2A (0.62) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| Hydrochloric Acid SCHEMBL6775619 | 0.98 | HTR2A (0.62) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| SCHEMBL6831079 | 0.88 | PPARG (0.60) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| SCHEMBL16131653 | 0.88 | HTR2A (0.69) | HTR2AHTR2CHTR2BEPHX1DPP4 | |
| SCHEMBL19943590 | 0.88 | HTR2A (0.69) | HTR2AHTR2CHTR2BEPHX1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1695 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719486-A1 | CONJUGATES AND USES THEREOF | Full-Life Technologies UK Limited (GB) | 2026-04-08 | — | — | EP | claimed |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | claimed |
| CN-120081924-A | GLP-1R receptor agonistic polypeptide compounds and uses thereof | 中国药科大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119390784-A | Dual-agonism polypeptide compound and medical application thereof | 中国药科大学 | 2025-02-07 | — | — | CN | claimed |
| WO-2024245407-A1 | CONJUGATES AND USES THEREOF | FULL-LIFE TECHNOLOGIES HK LIMITED (CN) | 2024-12-05 | — | — | WO | claimed |
| CN-118440155-B | Dual-agonism polypeptide compound and medical application thereof | 中国药科大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118546214-A | GLP-1R receptor agonistic polypeptide compounds and uses thereof | 中国药科大学 | 2024-08-27 | — | — | CN | claimed |
| CN-118440155-A | Dual-agonism polypeptide compound and medical application thereof | 中国药科大学 | 2024-08-06 | — | — | CN | claimed |
| WO-2023111350-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-06-22 | — | — | WO | claimed |
| CN-105143245-B | Anti-scaling material | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2021-02-05 | — | — | CN | claimed |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-01-26 | — | — | US | claimed |
| WO-2005122379-A2 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-22 | — | — | WO | claimed |
| US-6943157-B2 | Reverse-turn mimetics and composition and methods relating thereto | MYRIAD GENETICS, INC. (US) | 2005-09-13 | — | — | US | claimed |
| EP-0950046-B1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | NAEJA PHARMACEUTICAL INC (CA) | 2002-04-10 | — | — | EP | claimed |
| US-20020039749-A1 | High-throughput screening assays for modulators of STAT4 and STAT6 activity | AMGEN INC. | 2002-04-04 | — | — | US | claimed |
| US-6207391-B1 | INCUBATING A REACTION MIXTURE COMPRISING A STAT6 POLYPEPTIDE, A POTENTIAL BINDING MODULATOR, AND A RECEPTOR PEPTIDE WHICH COMPRISES A SPECIFIC AMINO ACID SEQUENCE | TULARIK INC. | 2001-03-27 | — | — | US | claimed |
| EP-0950046-A1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | SYNPHAR LABORATORIES INC. (CA) | 1999-10-20 | — | — | EP | claimed |
| WO-1999050283-A1 | HIGH THROUGHPUT SCREENING ASSAYS FOR MODULATORS OF STAT4 AND STAT6 ACTIVITY | TULARIK INC. (US) | 1999-10-07 | — | — | WO | claimed |
| US-5959123-A | REACATING SUBSTITUTED AMINO ACID WITH 3-AMINO-4-SUBSTITUTED-AZETIDINE-2-ONE COMPOUND TO FORM 3, 4-DISUBSTITUTED-AZETIDINE-2-ONE COMPOUND; USEFUL FOR TREATING MUSCULAR DYSTROPHY, ARTHRITIS, VIRAL AND PARASITIC INFECTIONS | SYNPHAR LABORATORIES, INC. (CA) | 1999-09-28 | — | — | US | claimed |
| WO-1998012176-A1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | SYNPHAR LABORATORIES INC. (US) | 1998-03-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | ITGA4, ITGB4, ITGA1 | HTR2A 3306/4885HTR2C 3517/4885HTR2B 1980/4885 |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | CA9, CA13, CA4 | HTR2A 4753/4885HTR2C 4780/4885HTR2B 4344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.